The cost-effectiveness of thrombolysis administered by paramedics^*

References

• Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-2 Investigators.. Single bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. The Lancet 1999; 354:716–22
   PubMed Web of Science ®Google Scholar
• Anon.. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence [International Joint Efficacy Comparison of Thrombolytics]. Lancet 1995; 346:329–36
   PubMed Web of Science ®Google Scholar
• Dundar Y, Hill R, Dickson R, . Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review [see comment]. QJM 2003; 96:103–13
   PubMed Web of Science ®Google Scholar
• Boland A, Dundar Y, Bagust A, . Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess 2003; 7:15
   Google Scholar
• National Heart Foundation of Australia, & Cardiac Society of Australia and New Zealand. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184 (Suppl 8) S1–S32
   Google Scholar
• Scottish Intercollegiate Guidelines Network. Acute coronary syndromes – a national clinical guidelineEdinburgh: Scottish Intercollegiate Guidelines Network, 2007
   Google Scholar
• Brouwer MA, Martin JS, Maynard C, . Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial) [MITI Project Investigators]. Am J Cardiol 1996; 78:497–502
   PubMed Web of Science ®Google Scholar
• Morrison LJ, Verbeek PR, McDonald AC, . Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. J Am Med Assoc 2000; 283:2686–92
   PubMed Web of Science ®Google Scholar
• Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1997; 30:1181–6
   PubMed Web of Science ®Google Scholar
• Department of Health, editor.. Coronary heart disease: national service frameworks: Department of Health. 2000
   Google Scholar
• Murray J, Rogers B. Early identification of patients for thrombolysis by intensive care paramedics – a pilot study. Paper presented to the Australian Resuscitation Council ConferenceGold Coast2004
   Google Scholar
• Criteria Committee of the American Heart Association (New York City Affiliate). Nomenclature and criteria for diagnosis of disease of the heart and great vessels, 9th edn. Boston, MA: Little Brown & Co., 1994
   Google Scholar
• The Gusto Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med 1993; 329:673–82
   PubMed Web of Science ®Google Scholar
• The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. New Engl J Med 1997; 337:1118–23
   PubMed Web of Science ®Google Scholar
• The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001; 357:1905–14
   PubMed Web of Science ®Google Scholar
• The Assessment of the Safety, & Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001; 358:605–13
   Google Scholar
• Van de Werf F, Adgey A, Agnelli G, . A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. New Engl J Med 1997; 337:1124–30
   PubMed Web of Science ®Google Scholar
• International Joint Efficacy Comparison of Thrombolytics. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995; 346:329–36
   PubMed Web of Science ®Google Scholar
• The InTIME-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 2000; 21:2005–13
   PubMed Web of Science ®Google Scholar
• Boersma E, Maas AC, Deckers JW, . Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour [see comment]. Lancet 1996; 348:771–5
   PubMed Web of Science ®Google Scholar
• Weaver WD, Simes RJ, Betriu A, . Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review [see comment][erratum appears in J Am Med Assoc 1998;279:1876]. J Am Med Assoc 1997; 278:2093–8
   PubMed Web of Science ®Google Scholar
• Zijlstra F, Hoorntje JC, de Boer MJ, . Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. New Engl J Med 1999; 341:1413–9
   PubMed Web of Science ®Google Scholar
• Zijlstra F, Patel A, Jones M, . Clinical characteristics and outcome of patients with early (<2 h), intermediate (2–4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23:550–7
   PubMed Web of Science ®Google Scholar
• Weiss AT, Leitersdorf I, Gotsman MS, . Prevention of congestive heart failure by early, prehospital thrombolysis in acute myocardial infarction: a long-term follow-up study. Int J Cardiol 1998; 65 (Suppl 1) S43–S48
   PubMed Web of Science ®Google Scholar
• Weaver WD, Cerqueira M, Hallstrom AP, . Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. J Am Med Assoc 1993; 270:1211–6
   PubMed Web of Science ®Google Scholar
• Kellett J, Clarke J. Comparison of ‘accelerated’ tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction. Medical Decision Making [an international journal of the Society for Medical Decision Making] 1995; 15:297–310
   PubMed Web of Science ®Google Scholar
• Kellett J. Cost-effectiveness of accelerated tissue plasminogen activator for acute myocardial infarction. Br J Med Econ 1996; 10:341–59
   Google Scholar
• TreeAge Pro [program]Williamstown, MA: TreeAge Software Inc., 2006
   Google Scholar
• Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Medical Decision Making 1993; 13:322–38
   PubMed Web of Science ®Google Scholar
• Hartwell D, Colquitt J, Loveman E, . Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess 2005; 9:1–114
   Web of Science ®Google Scholar
• Appleby P, Baigent C, Collins R, . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311–22
   PubMed Web of Science ®Google Scholar
• The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. New Engl J Med 1993; 329:383–9
   PubMed Web of Science ®Google Scholar
• ISIS-3 Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992; 339:753–70
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). GRIM (general record of incidence of mortality) booksCanberra: AIHW, 2005
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Cost weights for AR-DRG version 5.0, round 8 (2003–04) – Queensland National Hospital cost data collectionCanberra: AIHW, 2005
   Google Scholar
• Kirsch J, McGuire A. Establishing health state valuations for disease specific states: an example from heart disease. Health Econ 2000; 9:149–58
   PubMed Web of Science ®Google Scholar
• Hobbs FDR, Kenkre JE, Roalfe AK, . Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002; 23:1867–76
   PubMed Web of Science ®Google Scholar
• Tengs TO, Yu M, Luistro E. Health-related quality of life after stroke a comprehensive review. Stroke [a journal of cerebral circulation] 2001; 32:964–72
   PubMed Web of Science ®Google Scholar
• Post PN, Stiggelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke [a journal of cerebral circulation] 2001; 32:1425–9
   PubMed Web of Science ®Google Scholar
• Department of Health and Ageing. Pharmaceutical benefit schedule, April 2008Canberra: DoHA, Australian Government, 2008
   Google Scholar
• Commonwealth Department of Health and Ageing. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory CommitteeCanberra: Publications Production Unit, 2002
   Google Scholar
• George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991–1996). Pharmacoeconomics 2001; 19:1103–09
   PubMed Web of Science ®Google Scholar
• Chase D, Roderick P, Cooper K, . Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction. Emerg Med J 2006; 23:67–72
   PubMed Web of Science ®Google Scholar
• British Cardiovascular Intervention Society. Audit returns of interventional procedures 2004London: BCIS, 2004
   Google Scholar
• Antman EM, Anbe DT, Armstrong PW, . ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am College Cardiol 2004; 44:671–719
   PubMedGoogle Scholar
• Queensland Ambulance Service. The 12-lead ECG in paramedic practiceBrisbane: Queensland Ambulance Service, Department of Emergency Services, 2007
   Google Scholar
• Birkhead JS, Weston C, Lowe D. National audit of myocardial infarction project steering G. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004–5: observational study. Br Med J 2006; 332:1306–11
   PubMed Web of Science ®Google Scholar
• Bassand J-P, Hamm C. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology: reply. Eur Heart J 2008; 29:278–9
   Web of Science ®Google Scholar
• Rapezzi C, Biagini E, Branzi A. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2008; 29:277–8
   PubMed Web of Science ®Google Scholar
• Ljosland M, Weydahl PG, Stumberg S. Prehospital ECG reduces the delay of thrombolysis in acute myocardial infarction [in Norwegian]. Tidsskr Nor Laegeforen 2000; 120:2247–49
   PubMedGoogle Scholar
• Betriu A, Phillips H, Ellis E. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. New Engl J Med 1997; 336:1621–9
   PubMed Web of Science ®Google Scholar
• British Cardiovascular Intervention Society. Audit returns of interventional procedures 2001London: BCIS, 2001
   Google Scholar
• Department of Health and Ageing. Medicare benefits schedule bookCanberra: DoHA, Australian Government, 2004
   Google Scholar
• Department of Health and Ageing. Revised residential care fees and charges: schedule of fees and chargesCanberra: DoHA, Australian Government, 2004
   Google Scholar